Observational Study of Home Administration of Carfilzomib: Feasibility, Quality of Life and Description of the Process With Related Health-care Economics
Latest Information Update: 28 Sep 2022
At a glance
- Drugs Carfilzomib (Primary) ; Dexamethasone; Lenalidomide
- Indications Multiple myeloma
- Focus Adverse reactions
- Acronyms KARE-2
- 12 Nov 2020 New trial record